{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:10:20Z","timestamp":1790298620414,"version":"4.1.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007355","name":"Universidade Estadual Do Cear\u00e1","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007355","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00203-026-04989-1","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:32:14Z","timestamp":1780727534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting of Leishmania proteins by \u03b2-Lapachone derivatives reveals a promising multitarget candidate"],"prefix":"10.1007","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-804X","authenticated-orcid":false,"given":"La\u00e9rcio","family":"Mariano-Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5008-858X","authenticated-orcid":false,"given":"Jacilene","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0929-4565","authenticated-orcid":false,"given":"Matheus Nunes","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7640-2220","authenticated-orcid":false,"given":"M\u00e1rcia Machado","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4774-8775","authenticated-orcid":false,"given":"Emmanuel Silva","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"4989_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111508","volume":"138","author":"MAO Abdelfattah","year":"2021","unstructured":"Abdelfattah MAO, Ibrahim MA, Abdullahi HL et al (2021) Eugenia uniflora and Syzygium samarangense extracts exhibit anti-trypanosomal activity: evidence from in-silico molecular modelling, in vitro, and in vivo studies. Biomed Pharmacother 138:111508. https:\/\/doi.org\/10.1016\/j.biopha.2021.111508","journal-title":"Biomed Pharmacother"},{"key":"4989_CR2","doi-asserted-by":"publisher","first-page":"115471","DOI":"10.1016\/j.ejmech.2023.115471","volume":"257","author":"M Abirami","year":"2023","unstructured":"Abirami M, Karan Kumar B, Faheem et al (2023) Molecular-level strategic goals and repressors in Leishmaniasis \u2013 Integrated data to accelerate target-based heterocyclic scaffolds. Eur J Med Chem 257:115471. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115471","journal-title":"Eur J Med Chem"},{"key":"4989_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmd.2025.100044","volume":"53","author":"A Ailabouni","year":"2025","unstructured":"Ailabouni A, Prasad B (2025) Organic cation transporters 2: structure, regulation, functions, and clinical implications. Drug Metab Dispos 53:100044. https:\/\/doi.org\/10.1016\/j.dmd.2025.100044","journal-title":"Drug Metab Dispos"},{"key":"4989_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004349","volume":"10","author":"M Akhoundi","year":"2016","unstructured":"Akhoundi M, Kuhls K, Cannet A et al (2016) A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies. PLoS Negl Trop Dis 10:e0004349. https:\/\/doi.org\/10.1371\/journal.pntd.0004349","journal-title":"PLoS Negl Trop Dis"},{"key":"4989_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","volume":"22","author":"J Alvar","year":"2006","unstructured":"Alvar J, Yactayo S, Bern C (2006) Leishmaniasis and poverty. Trends Parasitol 22:552\u2013557. https:\/\/doi.org\/10.1016\/j.pt.2006.09.004","journal-title":"Trends Parasitol"},{"key":"4989_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C et al (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671. https:\/\/doi.org\/10.1371\/journal.pone.0035671","journal-title":"PLoS One"},{"key":"4989_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2958.2008.06131.x","volume":"68","author":"TL Arakaki","year":"2008","unstructured":"Arakaki TL, Buckner FS, Gillespie JR et al (2008) Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies. Mol Microbiol 68:37\u201350. https:\/\/doi.org\/10.1111\/j.1365-2958.2008.06131.x","journal-title":"Mol Microbiol"},{"key":"4989_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.exppara.2019.02.013","volume":"199","author":"IAC Ara\u00fajo","year":"2019","unstructured":"Ara\u00fajo IAC, De Paula RC, Alves CL et al (2019) Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis. Exp Parasitol 199:67\u201373. https:\/\/doi.org\/10.1016\/j.exppara.2019.02.013","journal-title":"Exp Parasitol"},{"key":"4989_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","volume":"46","author":"P Artursson","year":"2001","unstructured":"Artursson P, Palm K, Luthman K (2001) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 46:27\u201343. https:\/\/doi.org\/10.1016\/S0169-409X(00)00128-9","journal-title":"Adv Drug Deliv Rev"},{"key":"4989_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13318-016-0369-7","volume":"42","author":"M Bermejo","year":"2017","unstructured":"Bermejo M, Mangas-Sanjuan V, Gonzalez-Alvarez I, Gonzalez-Alvarez M (2017) Enhancing Oral Absorption of \u03b2-Lapachone: Progress Till Date. Eur J Drug Metab Pharmacokinet 42:1\u201310. https:\/\/doi.org\/10.1007\/s13318-016-0369-7","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"4989_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton GR, Paolini GV, Besnard J et al (2012) Quantifying the chemical beauty of drugs. Nat Chem 4:90\u201398. https:\/\/doi.org\/10.1038\/nchem.1243","journal-title":"Nat Chem"},{"key":"4989_CR12","doi-asserted-by":"publisher","first-page":"10326","DOI":"10.1021\/acs.jpcb.0c06399","volume":"124","author":"M Bogunia","year":"2020","unstructured":"Bogunia M, Makowski M (2020) Influence of Ionic Strength on Hydrophobic Interactions in Water: Dependence on Solute Size and Shape. J Phys Chem B 124:10326\u201310336. https:\/\/doi.org\/10.1021\/acs.jpcb.0c06399","journal-title":"J Phys Chem B"},{"key":"4989_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.freeradbiomed.2018.11.012","volume":"130","author":"ACS Bomba\u00e7a","year":"2019","unstructured":"Bomba\u00e7a ACS, Viana PG, Santos ACC et al (2019) Mitochondrial disfunction and ROS production are essential for anti-Trypanosoma cruzi activity of \u03b2-Lapachone-derived naphthoimidazoles. Free Radic Biol Med 130:408\u2013418. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.11.012","journal-title":"Free Radic Biol Med"},{"key":"4989_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jmb.2009.12.032","volume":"396","author":"JA Brannigan","year":"2010","unstructured":"Brannigan JA, Smith BA, Yu Z et al (2010) N-Myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis. J Mol Biol 396:985\u2013999. https:\/\/doi.org\/10.1016\/j.jmb.2009.12.032","journal-title":"J Mol Biol"},{"key":"4989_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1107\/S2052252514013001","volume":"1","author":"JA Brannigan","year":"2014","unstructured":"Brannigan JA, Roberts SM, Bell AS et al (2014) Diverse modes of binding in structures of Leishmania major N-Myristoyltransferase with selective inhibitors. IUCrJ 1:250\u2013260. https:\/\/doi.org\/10.1107\/S2052252514013001","journal-title":"IUCrJ"},{"key":"4989_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cmdc.200700139","volume":"3","author":"R Brenk","year":"2008","unstructured":"Brenk R, Schipani A, James D et al (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 3:435\u2013444. https:\/\/doi.org\/10.1002\/cmdc.200700139","journal-title":"ChemMedChem"},{"key":"4989_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155309","volume":"147","author":"MB Carneiro","year":"2021","unstructured":"Carneiro MB, Vaz LG, Afonso LCC et al (2021) Regulation of macrophage subsets and cytokine production in leishmaniasis. Cytokine 147:155309. https:\/\/doi.org\/10.1016\/j.cyto.2020.155309","journal-title":"Cytokine"},{"key":"4989_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/tropicalmed8100457","volume":"8","author":"MR Challapa-Mamani","year":"2023","unstructured":"Challapa-Mamani MR, Tom\u00e1s-Alvarado E, Espinoza-Baigorria A et al (2023) Molecular Docking and Molecular Dynamics Simulations in Related to Leishmania donovani: An Update and Literature Review. TropicalMed 8:457. https:\/\/doi.org\/10.3390\/tropicalmed8100457","journal-title":"TropicalMed"},{"key":"4989_CR19","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1016\/j.ejmech.2010.09.055","volume":"45","author":"J Cheleski","year":"2010","unstructured":"Cheleski J, Rocha JR, Pinheiro MP et al (2010) Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery. Eur J Med Chem 45:5899\u20135909. https:\/\/doi.org\/10.1016\/j.ejmech.2010.09.055","journal-title":"Eur J Med Chem"},{"key":"4989_CR20","doi-asserted-by":"publisher","first-page":"e1501240","DOI":"10.1126\/sciadv.1501240","volume":"2","author":"D Chen","year":"2016","unstructured":"Chen D, Oezguen N, Urvil P et al (2016) Regulation of protein-ligand binding affinity by hydrogen bond pairing. Sci Adv 2:e1501240. https:\/\/doi.org\/10.1126\/sciadv.1501240","journal-title":"Sci Adv"},{"key":"4989_CR21","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1186\/s12889-025-22477-x","volume":"25","author":"J Chen","year":"2025","unstructured":"Chen J, Tian X, Guo D et al (2025a) Global trends and burdens of neglected tropical diseases and malaria from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021. BMC Public Health 25:1307. https:\/\/doi.org\/10.1186\/s12889-025-22477-x","journal-title":"BMC Public Health"},{"key":"4989_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/biom15040525","volume":"15","author":"Y-Y Chen","year":"2025","unstructured":"Chen Y-Y, Liu C-X, Liu H-X, Wen S-Y (2025b) The Emerging Roles of Vacuolar-Type ATPase-Dependent Lysosomal Acidification in Cardiovascular Disease. Biomolecules 15:525. https:\/\/doi.org\/10.3390\/biom15040525","journal-title":"Biomolecules"},{"key":"4989_CR23","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3390\/pathogens11091052","volume":"11","author":"J Clos","year":"2022","unstructured":"Clos J, Gr\u00fcnebast J, Holm M (2022) Promastigote-to-Amastigote Conversion in Leishmania spp.\u2014A Molecular View. Pathogens 11:1052. https:\/\/doi.org\/10.3390\/pathogens11091052","journal-title":"Pathogens"},{"key":"4989_CR24","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.biochi.2012.04.003","volume":"94","author":"AT Cordeiro","year":"2012","unstructured":"Cordeiro AT, Feliciano PR, Pinheiro MP, Nonato MC (2012) Crystal structure of dihydroorotate dehydrogenase from Leishmania major. Biochimie 94:1739\u20131748. https:\/\/doi.org\/10.1016\/j.biochi.2012.04.003","journal-title":"Biochimie"},{"key":"4989_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1021\/acsinfecdis.8b00226","volume":"5","author":"V Corpas-Lopez","year":"2019","unstructured":"Corpas-Lopez V, Moniz S, Thomas M et al (2019) Pharmacological Validation of N -Myristoyltransferase as a Drug Target in Leishmania donovani. ACS Infect Dis 5:111\u2013122. https:\/\/doi.org\/10.1021\/acsinfecdis.8b00226","journal-title":"ACS Infect Dis"},{"key":"4989_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-11-S5-S5","volume":"11","author":"MG Costa","year":"2010","unstructured":"Costa MG, Batista PR, Shida CS et al (2010) How does heparin prevent the pH inactivation of cathepsin B? Allosteric mechanism elucidated by docking and molecular dynamics. BMC Genomics 11:S5. https:\/\/doi.org\/10.1186\/1471-2164-11-S5-S5","journal-title":"BMC Genomics"},{"key":"4989_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8074275","volume":"2017","author":"EVS Costa","year":"2017","unstructured":"Costa EVS, Br\u00edgido HPC, Silva JVDSE et al (2017) Antileishmanial activity of Handroanthus serratifolius (Vahl) S. Grose (Bignoniaceae). Evid Based Complement Alternat Med 2017:8074275. https:\/\/doi.org\/10.1155\/2017\/8074275","journal-title":"Evid Based Complement Alternat Med"},{"key":"4989_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12033-023-00748-5","volume":"66","author":"MN Da Rocha","year":"2024","unstructured":"Da Rocha MN, Da Fonseca AM, Dantas ANM et al (2024) In silico study in MPO and molecular docking of the synthetic Drynaran analogues against the chronic tinnitus: modulation of the M1 Muscarinic Acetylcholine Receptor. Mol Biotechnol 66:254\u2013269. https:\/\/doi.org\/10.1007\/s12033-023-00748-5","journal-title":"Mol Biotechnol"},{"key":"4989_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s40203-026-00590-y","volume":"14","author":"MVF Da Silva","year":"2026","unstructured":"Da Silva MVF, Silva J, Da Rocha MN et al (2026) In silico analysis of Anacardium occidentale phytochemicals: pharmacokinetics, molecular docking, and dynamics of Cryptococcus neoformans enzymes. In Silico Pharmacol 14:84. https:\/\/doi.org\/10.1007\/s40203-026-00590-y","journal-title":"In Silico Pharmacol"},{"key":"4989_CR30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00894-009-0468-3","volume":"15","author":"FA De Molfetta","year":"2009","unstructured":"De Molfetta FA, De Freitas RF, Da Silva ABF, Montanari CA (2009) Docking and molecular dynamics simulation of quinone compounds with trypanocidal activity. J Mol Model 15:1175\u20131184. https:\/\/doi.org\/10.1007\/s00894-009-0468-3","journal-title":"J Mol Model"},{"key":"4989_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s44371-025-00287-9","volume":"2","author":"VM De Oliveira","year":"2025","unstructured":"De Oliveira VM, Roberto CHA, Da Rocha MN et al (2025) Insights of ligand-based virtual screening in molecular docking and dynamics analysis of coumarin benzamides derivatives against leishmaniasis. Discov Chem 2:215. https:\/\/doi.org\/10.1007\/s44371-025-00287-9","journal-title":"Discov Chem"},{"key":"4989_CR32","doi-asserted-by":"crossref","unstructured":"De Souza AL, Nonato MC, Pinheiro MP (2012) Crystal Structure of Leishmania major dihydroorotate dehydrogenase mutant H174A: 3tjx","DOI":"10.2210\/pdb3tjx\/pdb"},{"key":"4989_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1128\/CMR.00067-12","volume":"26","author":"KJ Esch","year":"2013","unstructured":"Esch KJ, Petersen CA (2013) Transmission and Epidemiology of Zoonotic Protozoal Diseases of Companion Animals. Clin Microbiol Rev 26:58\u201385. https:\/\/doi.org\/10.1128\/CMR.00067-12","journal-title":"Clin Microbiol Rev"},{"key":"4989_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/B978-0-12-382163-8.00010-4","volume-title":"Quantitative Human Physiology","author":"J Feher","year":"2012","unstructured":"Feher J (2012) Cell Structure. Quantitative Human Physiology. Elsevier, pp 75\u201390"},{"key":"4989_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pep.2006.02.010","volume":"48","author":"PR Feliciano","year":"2006","unstructured":"Feliciano PR, Cordeiro AT, Costa-Filho AJ, Nonato MC (2006) Cloning, expression, purification, and characterization of Leishmania major dihydroorotate dehydrogenase. Protein Exp Purif 48:98\u2013103. https:\/\/doi.org\/10.1016\/j.pep.2006.02.010","journal-title":"Protein Exp Purif"},{"key":"4989_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.579891","volume":"8","author":"LFO Gervazoni","year":"2020","unstructured":"Gervazoni LFO, Barcellos GB, Ferreira-Paes T, Almeida-Amaral EE (2020) Use of natural products in leishmaniasis chemotherapy: an overview. Front Chem 8:579891. https:\/\/doi.org\/10.3389\/fchem.2020.579891","journal-title":"Front Chem"},{"key":"4989_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2021.112713","volume":"186","author":"CL Gomes","year":"2021","unstructured":"Gomes CL, De Albuquerque Wanderley Sales V, Gomes De Melo C et al (2021) Beta-lapachone: natural occurrence, physicochemical properties, biological activities, toxicity and synthesis. Phytochemistry 186:112713. https:\/\/doi.org\/10.1016\/j.phytochem.2021.112713","journal-title":"Phytochemistry"},{"key":"4989_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106931","volume":"141","author":"NBD Gomes","year":"2023","unstructured":"Gomes NBD, Magalh\u00e3es EP, Ribeiro LR et al (2023) Trypanocidal potential of synthetic p-aminochalcones: in silico and in vitro evaluation. Bioorg Chem 141:106931. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106931","journal-title":"Bioorg Chem"},{"key":"4989_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-025-01067-4","volume":"17","author":"J G\u00f3mez Borrego","year":"2025","unstructured":"G\u00f3mez Borrego J, Torrent Burgas M (2025) Evaluating ligand docking methods for drugging protein\u2013protein interfaces: insights from AlphaFold2 and molecular dynamics refinement. J Cheminform 17:144. https:\/\/doi.org\/10.1186\/s13321-025-01067-4","journal-title":"J Cheminform"},{"key":"4989_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2008.10.004","volume":"121","author":"JR G\u00f3mez Castellanos","year":"2009","unstructured":"G\u00f3mez Castellanos JR, Prieto JM, Heinrich M (2009) Red lapacho (Tabebuia impetiginosa)\u2014a global ethnopharmacological commodity? J Ethnopharmacol 121:1\u201313. https:\/\/doi.org\/10.1016\/j.jep.2008.10.004","journal-title":"J Ethnopharmacol"},{"key":"4989_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1021\/tx700079z","volume":"21","author":"FP Guengerich","year":"2008","unstructured":"Guengerich FP (2008) Cytochrome P450 and chemical toxicology. Chem Res Toxicol 21:70\u201383. https:\/\/doi.org\/10.1021\/tx700079z","journal-title":"Chem Res Toxicol"},{"key":"4989_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/571242","volume":"2011","author":"AK Haldar","year":"2011","unstructured":"Haldar AK, Sen P, Roy S (2011) Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int 2011:1\u201323. https:\/\/doi.org\/10.4061\/2011\/571242","journal-title":"Mol Biol Int"},{"key":"4989_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drudis.2017.09.006","volume":"23","author":"V Jain","year":"2018","unstructured":"Jain V, Jain K (2018) Molecular targets and pathways for the treatment of visceral leishmaniasis. Drug Discovery Today 23:161\u2013170. https:\/\/doi.org\/10.1016\/j.drudis.2017.09.006","journal-title":"Drug Discovery Today"},{"key":"4989_CR44","first-page":"535","volume":"100","author":"S Jain","year":"2025","unstructured":"Jain S, Ruiz-Postigo A, Maia-Elkhoury AN et al (2025) Global leishmaniasis surveillance updates 2024: consolidating gains and new initiatives. WER 100:535\u2013552","journal-title":"WER"},{"key":"4989_CR45","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1016\/j.bmcl.2009.08.045","volume":"19","author":"TW Johnson","year":"2009","unstructured":"Johnson TW, Dress KR, Edwards M (2009) Using the golden triangle to optimize clearance and oral absorption. Bioorg Med Chem Lett 19:5560\u20135564. https:\/\/doi.org\/10.1016\/j.bmcl.2009.08.045","journal-title":"Bioorg Med Chem Lett"},{"key":"4989_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/B978-012369520-8.50006-1","volume-title":"Drug-like Properties: Concepts, Structure Design and Methods","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L (2008) Lipophilicity. Drug-like properties: concepts, structure design and methods. Elsevier, pp 43\u201347"},{"key":"4989_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000701","volume":"4","author":"ID Kerr","year":"2010","unstructured":"Kerr ID, Wu P, Marion-Tsukamaki R et al (2010) Crystal structures of TbCatB and Rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei. PLoS Negl Trop Dis 4:e701. https:\/\/doi.org\/10.1371\/journal.pntd.0000701","journal-title":"PLoS Negl Trop Dis"},{"key":"4989_CR48","doi-asserted-by":"publisher","first-page":"13658","DOI":"10.1021\/acsomega.9b00843","volume":"4","author":"R Khalil","year":"2019","unstructured":"Khalil R, Ashraf S, Khalid A, Ul-Haq Z (2019) Exploring novel N -Myristoyltransferase inhibitors: a molecular dynamics simulation approach. ACS Omega 4:13658\u201313670. https:\/\/doi.org\/10.1021\/acsomega.9b00843","journal-title":"ACS Omega"},{"key":"4989_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fluid.2018.05.005","volume":"472","author":"KH Kim","year":"2018","unstructured":"Kim KH, Oh HK, Heo B et al (2018) Solubility evaluation and thermodynamic modeling of \u03b2-lapachone in water and ten organic solvents at different temperatures. Fluid Phase Equilib 472:1\u20138. https:\/\/doi.org\/10.1016\/j.fluid.2018.05.005","journal-title":"Fluid Phase Equilib"},{"key":"4989_CR50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"DB Kitchen","year":"2004","unstructured":"Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3:935\u2013949. https:\/\/doi.org\/10.1038\/nrd1549","journal-title":"Nat Rev Drug Discov"},{"key":"4989_CR51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nmeth.1859","volume":"9","author":"R Koopmann","year":"2012","unstructured":"Koopmann R, Cupelli K, Redecke L et al (2012) In vivo protein crystallization opens new routes in structural biology. Nat Methods 9:259\u2013262. https:\/\/doi.org\/10.1038\/nmeth.1859","journal-title":"Nat Methods"},{"key":"4989_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2024.101872","volume":"14","author":"S Kumar","year":"2025","unstructured":"Kumar S, Singhal A, Kumar P et al (2025) Toxicological evaluation of imidazo-based heterocyclic derivatives: in-vitro and in-vivo acute toxicity studies. Toxicol Rep 14:101872. https:\/\/doi.org\/10.1016\/j.toxrep.2024.101872","journal-title":"Toxicol Rep"},{"key":"4989_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","volume":"26","author":"R Laniado-Labor\u00edn","year":"2009","unstructured":"Laniado-Labor\u00edn R, Cabrales-Vargas MN (2009) Amphotericin B: side effects and toxicity. Rev Iberoam Micol 26:223\u2013227. https:\/\/doi.org\/10.1016\/j.riam.2009.06.003","journal-title":"Rev Iberoam Micol"},{"key":"4989_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005600","volume":"11","author":"T Lestinova","year":"2017","unstructured":"Lestinova T, Rohousova I, Sima M et al (2017) Insights into the sand fly saliva: blood-feeding and immune interactions between sand flies, hosts, and Leishmania. PLoS Negl Trop Dis 11:e0005600. https:\/\/doi.org\/10.1371\/journal.pntd.0005600","journal-title":"PLoS Negl Trop Dis"},{"key":"4989_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies 1:337\u2013341. https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007","journal-title":"Drug Discovery Today: Technologies"},{"key":"4989_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"key":"4989_CR57","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco JR, Aliaga JI, Quintana-Ort\u00ed ES, Chac\u00f3n P (2014) iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res 42:W271\u2013W276. https:\/\/doi.org\/10.1093\/nar\/gku339","journal-title":"Nucleic Acids Res"},{"key":"4989_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011497","volume":"17","author":"C Maia","year":"2023","unstructured":"Maia C, Concei\u00e7\u00e3o C, Pereira A et al (2023) The estimated distribution of autochthonous leishmaniasis by Leishmania infantum in Europe in 2005\u20132020. PLoS Negl Trop Dis 17:e0011497. https:\/\/doi.org\/10.1371\/journal.pntd.0011497","journal-title":"PLoS Negl Trop Dis"},{"key":"4989_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104365","volume":"148","author":"EM Marinho","year":"2020","unstructured":"Marinho EM, Batista De Andrade Neto J, Silva J et al (2020) Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease. Microbial Pathogenesis 148:104365. https:\/\/doi.org\/10.1016\/j.micpath.2020.104365","journal-title":"Microbial Pathogenesis"},{"key":"4989_CR60","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1007\/s00210-024-03138-z","volume":"397","author":"MM Marinho","year":"2024","unstructured":"Marinho MM, Da Rocha MN, Magalh\u00e3es EP et al (2024) Insights of potential trypanocidal effect of the synthetic derivative (2E)-1-(4-aminophenyl)-3-(2,4-dichlorophenyl)prop-2-en-1-one: in vitro assay, MEV analysis, quantum study, molecular docking, molecular dynamics, MPO analysis, and predictive ADMET. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 397:7797\u20137818. https:\/\/doi.org\/10.1007\/s00210-024-03138-z","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"4989_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"X-Y Meng","year":"2011","unstructured":"Meng X-Y, Zhang H-X, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7:146\u2013157. https:\/\/doi.org\/10.2174\/157340911795677602","journal-title":"Curr Comput Aided Drug Des"},{"key":"4989_CR62","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"4989_CR63","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/BJ20100337","volume":"429","author":"M Novinec","year":"2010","unstructured":"Novinec M, Kova\u010di\u010d L, Lenar\u010di\u010d B, Baici A (2010) Conformational flexibility and allosteric regulation of cathepsin K. Biochem J 429:379\u2013389. https:\/\/doi.org\/10.1042\/BJ20100337","journal-title":"Biochem J"},{"key":"4989_CR64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","volume":"118","author":"LF Oliveira","year":"2011","unstructured":"Oliveira LF, Schubach AO, Martins MM et al (2011) Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop 118:87\u201396. https:\/\/doi.org\/10.1016\/j.actatropica.2011.02.007","journal-title":"Acta Trop"},{"key":"4989_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106459","volume":"59","author":"S Pali\u0107","year":"2022","unstructured":"Pali\u0107 S, Beijnen JH, Dorlo TPC (2022) An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis. Int J Antimicrob Agents 59:106459. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106459","journal-title":"Int J Antimicrob Agents"},{"key":"4989_CR66","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1080\/07391102.2015.1085904","volume":"33","author":"RK Pandey","year":"2015","unstructured":"Pandey RK, Sharma D, Bhatt TK et al (2015) Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach. J Biomol Struct Dyn 33:2541\u20132553. https:\/\/doi.org\/10.1080\/07391102.2015.1085904","journal-title":"J Biomol Struct Dyn"},{"key":"4989_CR67","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1042\/BJ20051886","volume":"396","author":"C Panethymitaki","year":"2006","unstructured":"Panethymitaki C, Bowyer PW, Price HP et al (2006) Characterization and selective inhibition of myristoyl-CoA:protein N -myristoyltransferase from Trypanosoma brucei and Leishmania major. Biochem J 396:277\u2013285. https:\/\/doi.org\/10.1042\/BJ20051886","journal-title":"Biochem J"},{"key":"4989_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00663-w","volume":"11","author":"M Pareyn","year":"2025","unstructured":"Pareyn M, Alves F, Burza S et al (2025) Leishmaniasis. Nat Rev Dis Primers 11:81. https:\/\/doi.org\/10.1038\/s41572-025-00663-w","journal-title":"Nat Rev Dis Primers"},{"key":"4989_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26123537","volume":"26","author":"JF Peixoto","year":"2021","unstructured":"Peixoto JF, Oliveira ADS, Monteiro PQ et al (2021) In silico insights into the mechanism of action of Epoxy-\u03b1-Lapachone and Epoxymethyl-Lawsone in Leishmania spp. Molecules 26:3537. https:\/\/doi.org\/10.3390\/molecules26123537","journal-title":"Molecules"},{"key":"4989_CR70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijpddr.2019.10.004","volume":"11","author":"Y P\u00e9rez-Pertejo","year":"2019","unstructured":"P\u00e9rez-Pertejo Y, Escudero-Mart\u00ednez JM, Reguera RM et al (2019) Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB. Int J Parasitol Drugs Drug Resist 11:70\u201379. https:\/\/doi.org\/10.1016\/j.ijpddr.2019.10.004","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4989_CR71","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1002\/anie.201408487","volume":"54","author":"E Persch","year":"2015","unstructured":"Persch E, Dumele O, Diederich F (2015) Molecular Recognition in Chemical and Biological Systems. Angew Chem Int Ed 54:3290\u20133327. https:\/\/doi.org\/10.1002\/anie.201408487","journal-title":"Angew Chem Int Ed"},{"key":"4989_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104122","volume":"103","author":"MW Pertino","year":"2020","unstructured":"Pertino MW, De La Torre FA, Schmeda-Hirschmann G et al (2020) Synthesis, trypanocidal and anti-leishmania activity of new triazole-lapachol and nor-lapachol hybrids. Bioorg Chem 103:104122. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104122","journal-title":"Bioorg Chem"},{"key":"4989_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14111082","volume":"14","author":"A Plesko","year":"2025","unstructured":"Plesko A, Florea T, Imre M et al (2025) Canine leishmaniasis in Europe over the last decade: a review of geographic trends and epidemiological data. Pathogens 14:1082. https:\/\/doi.org\/10.3390\/pathogens14111082","journal-title":"Pathogens"},{"key":"4989_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2024.102211","volume":"112","author":"V Priolo","year":"2024","unstructured":"Priolo V, Ippolito D, Rivas-Estanga K et al (2024) Canine leishmaniosis global prevalence over the last three decades: a meta-analysis and systematic review. Comp Immunol Microbiol Infect Dis 112:102211. https:\/\/doi.org\/10.1016\/j.cimid.2024.102211","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"4989_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/minf.202060033","volume":"40","author":"M Rahman","year":"2021","unstructured":"Rahman M, Talukder A, Akter R (2021) Computational designing and prediction of ADMET properties of four novel imidazole-based drug candidates inhibiting heme Oxygenase\u20101 causing cancers. Mol Inform 40:2060033. https:\/\/doi.org\/10.1002\/minf.202060033","journal-title":"Mol Inform"},{"key":"4989_CR76","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00436-022-07455-1","volume":"121","author":"\u00c1CFH Ramos-Milar\u00e9","year":"2022","unstructured":"Ramos-Milar\u00e9 \u00c1CFH, Oyama J, Murase LS et al (2022) The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies. Parasitol Res 121:1247\u20131280. https:\/\/doi.org\/10.1007\/s00436-022-07455-1","journal-title":"Parasitol Res"},{"key":"4989_CR77","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10822-018-0105-2","volume":"32","author":"S Raschka","year":"2018","unstructured":"Raschka S, Wolf AJ, Bemister-Buffington J, Kuhn LA (2018) Protein\u2013ligand interfaces are polarized: discovery of a strong trend for intermolecular hydrogen bonds to favor donors on the protein side with implications for predicting and designing ligand complexes. J Comput Aided Mol Des 32:511\u2013528. https:\/\/doi.org\/10.1007\/s10822-018-0105-2","journal-title":"J Comput Aided Mol Des"},{"key":"4989_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2021.108039","volume":"110","author":"N Razzaghi-Asl","year":"2022","unstructured":"Razzaghi-Asl N, Hashemi N (2022) Identification of potential antileishmanial agents via structure-based molecular simulations. J Mol Graph Model 110:108039. https:\/\/doi.org\/10.1016\/j.jmgm.2021.108039","journal-title":"J Mol Graph Model"},{"key":"4989_CR79","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Dujardin J-C, Louzir H et al (2007) Cutaneous leishmaniasis. Lancet Infect Dis 7:581\u2013596. https:\/\/doi.org\/10.1016\/S1473-3099(07)70209-8","journal-title":"Lancet Infect Dis"},{"key":"4989_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3296893","volume":"2018","author":"RR Ribeiro","year":"2018","unstructured":"Ribeiro RR, Michalick MSM, Da Silva ME et al (2018) Canine Leishmaniasis: an overview of the current status and strategies for control. BioMed Res Int 2018:1\u201312. https:\/\/doi.org\/10.1155\/2018\/3296893","journal-title":"BioMed Res Int"},{"key":"4989_CR81","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.drudis.2010.11.014","volume":"16","author":"TJ Ritchie","year":"2011","unstructured":"Ritchie TJ, Macdonald SJF, Young RJ, Pickett SD (2011) The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types. Drug Discov Today 16:164\u2013171. https:\/\/doi.org\/10.1016\/j.drudis.2010.11.014","journal-title":"Drug Discov Today"},{"key":"4989_CR82","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13738-024-03166-9","volume":"22","author":"CHA Roberto","year":"2025","unstructured":"Roberto CHA, De Sousa DS, Da Silva Mendes FR et al (2025) Investigation of the anti-leishmanial potential of triazole-linked carvacrol\u2013coumarin derivatives: a docking, molecular dynamics, MM\/GBSA toxicity approach. J Iran Chem Soc 22:459\u2013473. https:\/\/doi.org\/10.1007\/s13738-024-03166-9","journal-title":"J Iran Chem Soc"},{"key":"4989_CR83","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","volume":"45","author":"A Rowland","year":"2013","unstructured":"Rowland A, Miners JO, Mackenzie PI (2013) The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification. Int J Biochem Cell Biol 45:1121\u20131132. https:\/\/doi.org\/10.1016\/j.biocel.2013.02.019","journal-title":"Int J Biochem Cell Biol"},{"key":"4989_CR84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2142\/biophysico.13.0_181","volume":"13","author":"T Sakano","year":"2016","unstructured":"Sakano T, Mahamood MI, Yamashita T, Fujitani H (2016) Molecular dynamics analysis to evaluate docking pose prediction. BIOPHYSICS 13:181\u2013194. https:\/\/doi.org\/10.2142\/biophysico.13.0_181","journal-title":"BIOPHYSICS"},{"key":"4989_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073008","volume":"28","author":"VLDA Santos","year":"2023","unstructured":"Santos VLDA, Gonsalves ADA, Guimar\u00e3es DG et al (2023) Naphth[1,2-d]imidazoles bioactive from \u03b2-Lapachone: fluorescent probes and cytotoxic agents to cancer cells. Molecules 28:3008. https:\/\/doi.org\/10.3390\/molecules28073008","journal-title":"Molecules"},{"key":"4989_CR86","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/vde.70006","volume":"36","author":"MN Saridomichelakis","year":"2025","unstructured":"Saridomichelakis MN, Baneth G, Colombo S et al (2025) World Association for Veterinary Dermatology consensus statement for diagnosis, and evidence-based clinical practice guidelines for treatment and prevention of canine leishmaniosis. Vet Dermatol 36:723\u2013787. https:\/\/doi.org\/10.1111\/vde.70006","journal-title":"Vet Dermatol"},{"key":"4989_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-025-07042-0","volume":"18","author":"J Sarquis","year":"2025","unstructured":"Sarquis J, Sanz CR, Raposo LM et al (2025) Unveiling prognostic indicators in canine leishmaniosis: two decades of evidence. Parasit Vectors 18:467. https:\/\/doi.org\/10.1186\/s13071-025-07042-0","journal-title":"Parasit Vectors"},{"key":"4989_CR88","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12639-014-0444-4","volume":"40","author":"F Sasani","year":"2016","unstructured":"Sasani F, Javanbakht J, Samani R, Shirani D (2016) Canine cutaneous leishmaniasis. J Parasit Dis 40:57\u201360. https:\/\/doi.org\/10.1007\/s12639-014-0444-4","journal-title":"J Parasit Dis"},{"key":"4989_CR89","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1002\/cphc.202000665","volume":"21","author":"S Saxena","year":"2020","unstructured":"Saxena S, Panchagnula S, Sanz ME et al (2020) Structural changes induced by quinones: high-resolution microwave study of 1,4\u2010naphthoquinone. ChemPhysChem 21:2579\u20132584. https:\/\/doi.org\/10.1002\/cphc.202000665","journal-title":"ChemPhysChem"},{"key":"4989_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2024.102863","volume":"100","author":"SY Sheikh","year":"2024","unstructured":"Sheikh SY, Hassan F, Shukla D et al (2024) A review on potential therapeutic targets for the treatment of leishmaniasis. Parasitol Int 100:102863. https:\/\/doi.org\/10.1016\/j.parint.2024.102863","journal-title":"Parasitol Int"},{"key":"4989_CR91","doi-asserted-by":"publisher","DOI":"10.2147\/AABC.S63749","author":"S Shityakov","year":"2014","unstructured":"Shityakov S, Foerster C (2014) In silico predictive model to determine vector-mediated transport properties for the blood–brain barrier choline transporter. AABC. https:\/\/doi.org\/10.2147\/AABC.S63749","journal-title":"AABC"},{"key":"4989_CR92","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"4989_CR93","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H Van De Waterbeemd","year":"2003","unstructured":"Van De Waterbeemd H, Gifford E (2003) ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2:192\u2013204. https:\/\/doi.org\/10.1038\/nrd1032","journal-title":"Nat Rev Drug Discov"},{"key":"4989_CR94","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","volume":"92","author":"JI Vandenberg","year":"2012","unstructured":"Vandenberg JI, Perry MD, Perrin MJ et al (2012) hERG K+ channels: structure, function, and clinical significance. Physiol Rev 92:1393\u20131478. https:\/\/doi.org\/10.1152\/physrev.00036.2011","journal-title":"Physiol Rev"},{"key":"4989_CR95","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y et al (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"key":"4989_CR96","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1002\/jcc.21538","volume":"31","author":"SK Venkatesan","year":"2010","unstructured":"Venkatesan SK, Shukla AK, Dubey VK (2010) Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum. J Comput Chem 31:2463\u20132475. https:\/\/doi.org\/10.1002\/jcc.21538","journal-title":"J Comput Chem"},{"key":"4989_CR97","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.3390\/molecules14114570","volume":"14","author":"A Ventura Pinto","year":"2009","unstructured":"Ventura Pinto A, Lisboa De Castro S (2009) The trypanocidal activity of naphthoquinones: a review. Molecules 14:4570\u20134590. https:\/\/doi.org\/10.3390\/molecules14114570","journal-title":"Molecules"},{"key":"4989_CR98","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1080\/07391102.2016.1195283","volume":"35","author":"B Vera","year":"2017","unstructured":"Vera B, V\u00e1zquez K, Mascayano C et al (2017) Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data. J Biomol Struct Dyn 35:1785\u20131803. https:\/\/doi.org\/10.1080\/07391102.2016.1195283","journal-title":"J Biomol Struct Dyn"},{"key":"4989_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13060455","volume":"13","author":"DF Vilas-Boas","year":"2024","unstructured":"Vilas-Boas DF, Nakasone EKN, Gon\u00e7alves AAM et al (2024) Global distribution of Canine Visceral Leishmaniasis and the role of the dog in the epidemiology of the disease. Pathogens 13:455. https:\/\/doi.org\/10.3390\/pathogens13060455","journal-title":"Pathogens"},{"key":"4989_CR100","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/cn100007x","volume":"1","author":"TT Wager","year":"2010","unstructured":"Wager TT, Chandrasekaran RY, Hou X et al (2010a) Defining desirable Central Nervous System drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. ACS Chem Neurosci 1:420\u2013434. https:\/\/doi.org\/10.1021\/cn100007x","journal-title":"ACS Chem Neurosci"},{"key":"4989_CR101","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/cn100008c","volume":"1","author":"TT Wager","year":"2010","unstructured":"Wager TT, Hou X, Verhoest PR, Villalobos A (2010b) Moving beyond rules: the development of a Central Nervous System multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. ACS Chem Neurosci 1:435\u2013449. https:\/\/doi.org\/10.1021\/cn100008c","journal-title":"ACS Chem Neurosci"},{"key":"4989_CR102","unstructured":"WHO (2023) Leishmaniasis. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis. Accessed 22 Jan 2026"},{"key":"4989_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05786-0","volume":"14","author":"Z Xie","year":"2023","unstructured":"Xie Z, Zhao M, Yan C et al (2023) Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways. Cell Death Dis 14:255. https:\/\/doi.org\/10.1038\/s41419-023-05786-0","journal-title":"Cell Death Dis"},{"key":"4989_CR104","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202102001","volume":"220","author":"C Yang","year":"2021","unstructured":"Yang C, Wang X (2021) Lysosome biogenesis: Regulation and functions. J Cell Biol 220:e202102001. https:\/\/doi.org\/10.1083\/jcb.202102001","journal-title":"J Cell Biol"},{"key":"4989_CR105","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1021\/ci800084x","volume":"48","author":"D Yusuf","year":"2008","unstructured":"Yusuf D, Davis AM, Kleywegt GJ, Schmitt S (2008) An Alternative Method for the Evaluation of Docking Performance: RSR vs RMSD. J Chem Inf Model 48:1411\u20131422. https:\/\/doi.org\/10.1021\/ci800084x","journal-title":"J Chem Inf Model"},{"key":"4989_CR106","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103\u2013141. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.12.007","journal-title":"Pharmacol Ther"},{"key":"4989_CR107","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-981-10-5187-6_8","volume-title":"Drug Design: Principles and Applications","author":"HA Zhong","year":"2017","unstructured":"Zhong HA (2017) ADMET Properties: Overview and Current Topics. In: Grover A (ed) Drug Design: Principles and Applications. Springer Singapore, Singapore, pp 113\u2013133"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04989-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04989-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04989-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:05:53Z","timestamp":1785571553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04989-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":107,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4989"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04989-1","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Comflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"428"}}